デフォルト表紙
市場調査レポート
商品コード
1705541

オルガノイドとスフェロイドの世界市場レポート 2025年

Organoids And Spheroids Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
オルガノイドとスフェロイドの世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

オルガノイドとスフェロイド市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR24.4%で34億6,000万米ドルに成長します。予測期間の成長は、継続的な技術進歩、個別化医療の拡大、がん研究における応用の強化、倫理的・規制的進化、オルガノイドおよびスフェロイド技術に基づく商業製品・サービスの成長、オルガノイドおよびスフェロイド技術の研究者を育成する教育イニシアチブの増加などに起因すると考えられます。予測期間における主な動向としては、先端技術との統合、創薬に向けたオルガノイドを用いたハイスループットスクリーニング法の拡大、3Dバイオプリンティングとバイオファブリケーション、各種がんのモデル化に向けたオルガノイド利用の増加、オルガノイドとマイクロ流体システムとの統合などが挙げられます。

細胞治療と組織工学に対する需要の高まりが、今後のオルガノイドとスフェロイド市場の拡大を牽引すると予想されます。細胞療法と組織工学は、体内の損傷した組織や臓器を置換、修復、再生するために生きた細胞や人工組織を利用するものです。これらの治療法は、損傷した組織を再生し、以前は不治の病と考えられていた状態を治療する可能性があるため、再生医療における革新的なソリューションを提供することになり、この需要は増加しています。オルガノイドとスフェロイドは、細胞治療や組織工学において、複雑な組織をモデル化し、試験管内で治療アプローチを試験するために使用されます。例えば、2023年2月、米国を拠点とする研究者のためのオンラインリソースであるCell &Geneは、2022年に承認された340の生物製剤の約8%に相当する27のFDA承認細胞・遺伝子治療(CGT)があり、2021年の22の承認から増加していると報告しています。このような細胞療法と組織工学に対する需要の高まりは、オルガノイドとスフェロイド市場の成長を支えるものと予想されます。

オルガノイドとスフェロイド市場の主要企業は、細胞ハンドリングの精度を高め、研究成果の再現性を向上させるため、単粒子分散器などの先進ツールの開発に注力しています。一粒子分注装置は、個々の細胞や粒子を分離・分注するように設計された高精度の装置であり、研究や診断アプリケーションにおける正確な制御を可能にします。例えば、スイスに本社を置くバイオテクノロジー企業SEED Biosciences社は、2024年7月、個々のスフェロイドやオルガノイドを正確に分注する革新的なツールDispen3Dを発売しました。このディスペンサーにより、研究者は単一のスフェロイドを迅速かつ正確にマルチウェルプレートに移し、プロセスを自動化し、創薬や個別化医療に不可欠な単クローン性を確保することができます。Dispen3Dは低圧で作動し、壊れやすい細胞を繊細に処理し、その構造的完全性と生存性を維持します。また、ユーザーフレンドリーな設計により、多様な研究環境にシームレスに統合することができ、生物科学における高度な機器への需要の高まりに応えます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界オルガノイドとスフェロイド PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のオルガノイドとスフェロイド市場:成長率分析
  • 世界のオルガノイドとスフェロイド市場の実績:規模と成長, 2019-2024
  • 世界のオルガノイドとスフェロイド市場の予測:規模と成長, 2024-2029, 2034F
  • 世界オルガノイドとスフェロイド総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のオルガノイドとスフェロイド市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オルガノイド
  • 球状体
  • 世界のオルガノイドとスフェロイド市場:方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 細胞外マトリックススキャフォールド法
  • 回転式バイオリアクター法
  • ハンギングドロップ法
  • 低接着培養プレート法
  • 磁気浮上方式
  • その他の方法
  • 世界のオルガノイドとスフェロイド市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 発生生物学
  • パーソナライズ医療
  • 再生医療
  • 疾患病理学研究
  • 薬物の毒性と有効性試験
  • 世界のオルガノイドとスフェロイド市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バイオテクノロジーと製薬業界
  • 学術研究機関
  • 病院と診断センター
  • 世界のオルガノイドとスフェロイド市場オルガノイドのサブセグメンテーション(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 腸管オルガノイド
  • 肝臓オルガノイド
  • 脳オルガノイド
  • 腎臓オルガノイド
  • 肺オルガノイド
  • 膵臓オルガノイド
  • 心臓オルガノイド
  • 網膜オルガノイド
  • 腫瘍オルガノイド
  • 疾患モデルのためのオルガノイド
  • 世界のオルガノイドとスフェロイド市場、タイプ別スフェロイドのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • がんスフェロイド
  • 神経球状体
  • 心臓スフェロイド
  • 肝スフェロイド
  • 筋肉球状体
  • 内皮細胞スフェロイド
  • 幹細胞由来スフェロイド
  • 3D細胞培養スフェロイド

第7章 地域別・国別分析

  • 世界のオルガノイドとスフェロイド市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のオルガノイドとスフェロイド市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • オルガノイドとスフェロイド市場:競合情勢
  • オルガノイドとスフェロイド市場:企業プロファイル
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • StemCell Technologies Canada Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Greiner Bio-One International AG
  • Promega Corporation
  • Molecular Devices LLC
  • American Type Culture Collection(ATCC)
  • Mimetas B.V.
  • InSphero AG
  • HUB Organoids
  • Emulate Inc.
  • 3D Biomatrix Inc.
  • Prellis Biologics Inc.
  • 3D Biotek LLC
  • DefiniGEN Limited
  • Visikol Inc.
  • Organovo Holdings Inc.
  • Cellesce Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • オルガノイドとスフェロイド市場2029:新たな機会を提供する国
  • オルガノイドとスフェロイド市場2029:新たな機会を提供するセグメント
  • オルガノイドとスフェロイド市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r30855

Organoids and spheroids are advanced 3D cell culture systems designed to replicate the structure and function of organs and tissues. Organoids are small, simplified versions of organs created from stem cells, while spheroids are spherical clusters of cells that can model tumor environments or various tissue types. These systems are utilized for research purposes such as disease modeling and drug testing.

The primary types of these models are organoids and spheroids. Organoids are miniature organ replicas grown in vitro from stem cells, used for investigating organ development, disease mechanisms, and drug effects. Techniques for generating organoids include the extracellular matrix scaffold method, spinning bioreactor method, hanging drop method, low adherent culture plate method, magnetic levitation method, and others. Applications of these models span developmental biology, personalized and regenerative medicine, disease pathology, drug toxicity studies, and efficacy testing. Key users include the biotechnology and pharmaceutical industries, academic and research institutions, and hospitals and diagnostic centers.

The organoids and spheroids market research report is one of a series of new reports from The Business Research Company that provides organoids and spheroids market statistics, including the organoids and spheroids industry's global market size, regional shares, competitors with an organoids and spheroids market share, detailed organoids and spheroids market segments, market trends and opportunities, and any further data you may need to thrive in the organoids and spheroids industry. This organoids and spheroids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The organoids and spheroids market size has grown exponentially in recent years. It will grow from $1.16 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 24.6%. The growth in the historic period can be attributed to rapid progress in stem cell research and 3d cell culture technologies, increased funding and investments, rise in chronic diseases, increased use of organoids and spheroids in drug screening and toxicology studies, progress in regenerative medicine and personalized medicine approaches, favorable regulatory frameworks supporting the use of advanced cell culture models in research.

The organoids and spheroids market size is expected to see exponential growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 24.4%. The growth in the forecast period can be attributed to continued technological advancements, expansion of personalized medicine, enhanced applications in cancer research, ethical and regulatory evolution, growth in commercial products and services based on organoid and spheroid technologies, increased educational initiatives to train researchers in organoid and spheroid technologies. Major trends in the forecast period include integration with advanced technologies, expansion of high-throughput screening methods using organoids for drug discovery, 3D bioprinting and bio fabrication, increasing use of organoids for modeling various cancers, and integration of organoids with microfluidic systems.

The growing demand for cell therapy and tissue engineering is expected to drive the expansion of the organoids and spheroids market in the future. Cell therapy and tissue engineering involve utilizing living cells or engineered tissues to replace, repair, or regenerate damaged tissues and organs in the body. This demand is increasing due to the potential of these therapies to regenerate damaged tissues and treat conditions previously considered incurable, thus providing innovative solutions in regenerative medicine. Organoids and spheroids are used in cell therapy and tissue engineering to model complex tissues and test therapeutic approaches in vitro. For example, in February 2023, Cell & Gene, a U.S.-based online resource for research scholars, reported that there were 27 FDA-approved cell and gene therapies (CGTs), representing about 8% of the 340 biologics approved in 2022, an increase from 22 approvals in 2021. This growing demand for cell therapy and tissue engineering is anticipated to support the growth of the organoids and spheroids market.

Leading companies in the organoids and spheroids market are concentrating on developing advanced tools, such as single-particle dispensers, to enhance precision in cell handling and improve the reproducibility of research outcomes. Single-particle dispensers are high-precision instruments designed to isolate and dispense individual cells or particles, enabling accurate control in research and diagnostic applications. For example, in July 2024, SEED Biosciences, a biotechnology company based in Switzerland, launched Dispen3D, an innovative tool for accurately dispensing individual spheroids and organoids, representing a significant advancement in 3D cellular model handling. This dispenser allows researchers to transfer single spheroids into multi-well plates swiftly and precisely, automating the process and ensuring monoclonality, which is essential for drug discovery and personalized medicine. Dispen3D operates at low pressures, delicately treating fragile cells to maintain their structural integrity and viability, while its user-friendly design allows for seamless integration into diverse research settings, meeting the increasing demand for advanced instruments in biological sciences.

In February 2024, Cell Microsystems, a U.S.-based biotechnology company, formed a strategic partnership with OMNI Life Science to significantly advance life science research in North America through the introduction of advanced cell analysis tools. This collaboration focuses on launching three innovative products: the TIGR Tissue Grinder & Dissociator, the CASY Cell Counter and Analyzer, and the CERO 3D Cell Culture Incubator & Bioreactor. OMNI Life Science, a Germany-based company, specializes in laboratory instrumentation and solutions for life sciences research.

Major companies operating in the organoids and spheroids market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, StemCell Technologies Canada Inc., Greiner Bio-One International AG, Promega Corporation, Molecular Devices LLC, American Type Culture Collection (ATCC), Mimetas B.V., InSphero AG, HUB Organoids, Emulate Inc., 3D Biomatrix Inc., Prellis Biologics Inc., 3D Biotek LLC, DefiniGEN Limited, Visikol Inc., Organovo Holdings Inc., Cellesce Ltd., AMS Biotechnology (Europe) Limited

North America was the largest region in the organoids and spheroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoids and spheroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the organoids and spheroids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The organoids and spheroids market includes revenues earned by entities by providing services such as drug discovery and testing, toxicology screening, personalized medicine, regenerative medicine research, cancer research, stem cell research, and gene editing studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Organoids And Spheroids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organoids and spheroids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organoids and spheroids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The organoids and spheroids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Organoids; Spheroids
  • 2) By Method: Extracellular Matrix Scaffold Method; Spinning Bioreactor Method; Hanging Drop Method; Low Adherent Culture Plate Method; Magnetic levitation Method; Other Methods
  • 3) By Application: Developmental Biology; Personalized Medicine; Regenerative Medicine; Disease Pathology Studies; Drug Toxicity And Efficacy Testing
  • 4) By End User: Biotechnology And Pharmaceutical Industry; Academic And Research Institutes; Hospitals And Diagnostic Centers
  • Subsegments:
  • 1) By Organoids: Intestinal Organoids; Liver Organoids; Brain Organoids; Kidney Organoids; Lung Organoids; Pancreatic Organoids; Cardiac Organoids; Retinal Organoids; Tumor Organoids; Organoids For Disease Modeling
  • 2) By Spheroids: Cancer Spheroids; Neural Spheroids; Cardiac Spheroids; Liver Spheroids; Muscle Spheroids; Endothelial Spheroids; Stem Cell-Derived Spheroids; 3D Cell Culture Spheroids
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Corning Incorporated; Lonza Group AG; StemCell Technologies Canada Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Organoids And Spheroids Market Characteristics

3. Organoids And Spheroids Market Trends And Strategies

4. Organoids And Spheroids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Organoids And Spheroids Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Organoids And Spheroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Organoids And Spheroids Market Growth Rate Analysis
  • 5.4. Global Organoids And Spheroids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Organoids And Spheroids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Organoids And Spheroids Total Addressable Market (TAM)

6. Organoids And Spheroids Market Segmentation

  • 6.1. Global Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organoids
  • Spheroids
  • 6.2. Global Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Extracellular Matrix Scaffold Method
  • Spinning Bioreactor Method
  • Hanging Drop Method
  • Low Adherent Culture Plate Method
  • Magnetic Levitation Method
  • Other Methods
  • 6.3. Global Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity And Efficacy Testing
  • 6.4. Global Organoids And Spheroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biotechnology And Pharmaceutical Industry
  • Academic And Research Institutes
  • Hospitals And Diagnostic Centers
  • 6.5. Global Organoids And Spheroids Market, Sub-Segmentation Of Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intestinal Organoids
  • Liver Organoids
  • Brain Organoids
  • Kidney Organoids
  • Lung Organoids
  • Pancreatic Organoids
  • Cardiac Organoids
  • Retinal Organoids
  • Tumor Organoids
  • Organoids For Disease Modeling
  • 6.6. Global Organoids And Spheroids Market, Sub-Segmentation Of Spheroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Spheroids
  • Neural Spheroids
  • Cardiac Spheroids
  • Liver Spheroids
  • Muscle Spheroids
  • Endothelial Spheroids
  • Stem Cell-Derived Spheroids
  • 3D Cell Culture Spheroids

7. Organoids And Spheroids Market Regional And Country Analysis

  • 7.1. Global Organoids And Spheroids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Organoids And Spheroids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Organoids And Spheroids Market

  • 8.1. Asia-Pacific Organoids And Spheroids Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Organoids And Spheroids Market

  • 9.1. China Organoids And Spheroids Market Overview
  • 9.2. China Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Organoids And Spheroids Market

  • 10.1. India Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Organoids And Spheroids Market

  • 11.1. Japan Organoids And Spheroids Market Overview
  • 11.2. Japan Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Organoids And Spheroids Market

  • 12.1. Australia Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Organoids And Spheroids Market

  • 13.1. Indonesia Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Organoids And Spheroids Market

  • 14.1. South Korea Organoids And Spheroids Market Overview
  • 14.2. South Korea Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Organoids And Spheroids Market

  • 15.1. Western Europe Organoids And Spheroids Market Overview
  • 15.2. Western Europe Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Organoids And Spheroids Market

  • 16.1. UK Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Organoids And Spheroids Market

  • 17.1. Germany Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Organoids And Spheroids Market

  • 18.1. France Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Organoids And Spheroids Market

  • 19.1. Italy Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Organoids And Spheroids Market

  • 20.1. Spain Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Organoids And Spheroids Market

  • 21.1. Eastern Europe Organoids And Spheroids Market Overview
  • 21.2. Eastern Europe Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Organoids And Spheroids Market

  • 22.1. Russia Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Organoids And Spheroids Market

  • 23.1. North America Organoids And Spheroids Market Overview
  • 23.2. North America Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Organoids And Spheroids Market

  • 24.1. USA Organoids And Spheroids Market Overview
  • 24.2. USA Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Organoids And Spheroids Market

  • 25.1. Canada Organoids And Spheroids Market Overview
  • 25.2. Canada Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Organoids And Spheroids Market

  • 26.1. South America Organoids And Spheroids Market Overview
  • 26.2. South America Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Organoids And Spheroids Market

  • 27.1. Brazil Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Organoids And Spheroids Market

  • 28.1. Middle East Organoids And Spheroids Market Overview
  • 28.2. Middle East Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Organoids And Spheroids Market

  • 29.1. Africa Organoids And Spheroids Market Overview
  • 29.2. Africa Organoids And Spheroids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Organoids And Spheroids Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Organoids And Spheroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Organoids And Spheroids Market Competitive Landscape And Company Profiles

  • 30.1. Organoids And Spheroids Market Competitive Landscape
  • 30.2. Organoids And Spheroids Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. StemCell Technologies Canada Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Organoids And Spheroids Market Other Major And Innovative Companies

  • 31.1. Greiner Bio-One International AG
  • 31.2. Promega Corporation
  • 31.3. Molecular Devices LLC
  • 31.4. American Type Culture Collection (ATCC)
  • 31.5. Mimetas B.V.
  • 31.6. InSphero AG
  • 31.7. HUB Organoids
  • 31.8. Emulate Inc.
  • 31.9. 3D Biomatrix Inc.
  • 31.10. Prellis Biologics Inc.
  • 31.11. 3D Biotek LLC
  • 31.12. DefiniGEN Limited
  • 31.13. Visikol Inc.
  • 31.14. Organovo Holdings Inc.
  • 31.15. Cellesce Ltd.

32. Global Organoids And Spheroids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Organoids And Spheroids Market

34. Recent Developments In The Organoids And Spheroids Market

35. Organoids And Spheroids Market High Potential Countries, Segments and Strategies

  • 35.1 Organoids And Spheroids Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Organoids And Spheroids Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Organoids And Spheroids Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer